Form 4 for IDXX Idexx Laboratories
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-11 · accession 0000874716-25-000137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-13 | 2025-08-12 | IDXX | Hunt Nimrata | EVP | M - OptEx | $244.16 | +1,226 | 17.8K | +7% | +$299.3K |
| D | 2025-08-13 | 2025-08-11 | IDXX | Hunt Nimrata | EVP | S - Sale+OE | $656.53 | -1,200 | 16.8K | -7% | -$787.8K |
| DM | 2025-08-13 | 2025-08-12 | IDXX | Hunt Nimrata | EVP | M - OptEx | $0.00 | -1,226 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | M | A | 560 | $178.26 | 17,366.94 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-11 | S | D | 1,200 | $656.53 | 16,806.94 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-12 | M | A | 183 | $544.08 | 18,032.94 | D | — | — | |
| 4 | Common | Common Stock | 2025-08-12 | M | A | 483 | $206.94 | 17,849.94 | D | — | — | |
| 5 | Derivative | Incentive Stock Option (right-to-buy) | 2025-08-12 | M | D | 183 | $0.00 | 0 | D | $544.08 · — to 2031-02-13 | 183 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025. |
| 6 | Derivative | Incentive Stock Option (right-to-buy) | 2025-08-12 | M | D | 483 | $0.00 | 0 | D | $206.94 · — to 2029-02-13 | 483 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2024. |
| 7 | Derivative | Incentive Stock Option (right-to-buy) | 2025-08-12 | M | D | 560 | $0.00 | 0 | D | $178.26 · — to 2028-02-13 | 560 Common Stock | (F1) Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2023. |